InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the complete record of transactions filed by Caffo Nathan, Directeur Commercial. Director active across 1 company, notably Candel Therapeutics, Inc.. In total, 1 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €40k. Activity tracked since 29 July 2021. The latest transaction was filed on 29 July 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Caffo Nathan is the Chief Business Officer at Candel Therapeutics, Inc. In this role, he is responsible for business strategy and partnership development. His expertise in the biopharmaceutical sector enables him to guide the company towards sustainable growth. Nathan works closely with teams to align business initiatives with strategic objectives.